| View |
|
DRP-10874-01
|
Ceftriaxone (as sodium) + Sulbactam (as sodium)
|
Triacebact
|
1 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin - Beta-Lactamase Inhibitor Combination)
|
Theon Pharmaceuticals Limited
|
India
|
-
|
05 May 2022
|
10 December 2026
|
| View |
|
DRP-8517-01
|
Irbesartan
|
Belizar
|
150 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Intas Pharmaceuticals Limited
|
India
|
Renewal
|
21 October 2024
|
24 October 2029
|
| View |
|
DRP-6758-15
|
Paracetamol + Vitamin B-Complex
|
Alapain
|
500 mg/50 mg/100 mg/100 mcg
|
Film-Coated Tablet
|
Analgesic/ Antipyretic/ Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
16 January 2024
|
18 February 2029
|
| View |
|
DRP-6523-02
|
Ivabradine (as hydrochloride)
|
Bravadine
|
7.5mg
|
Film-Coated Tablet
|
Anti-angina
|
Bafna Pharmaceuticals Ltd
|
India
|
-
|
05 May 2022
|
03 February 2026
|
| View |
|
DRP-5044-05
|
Fenofibrate
|
Fenok
|
100 mg
|
Capsule
|
Hypertriglyceridemia
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
16 February 2024
|
07 January 2029
|
| View |
|
DRP-5043-03
|
Fenofibrate
|
Fenok
|
67 mg
|
Capsule
|
Hypertriglyceridemia
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Renewal
|
14 February 2024
|
07 January 2029
|
| View |
|
DRP-4830-03
|
Fenofibrate
|
Fenok
|
300 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
Renewal
|
24 October 2023
|
16 October 2028
|
| View |
|
DRP-4458-08
|
Amlodipine (as besilate)
|
Amlosky
|
10 mg
|
Tablet
|
Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
03 October 2022
|
06 June 2028
|
| View |
|
DRP-4061-06
|
Multivitamins + Dextrose
|
Akeedex
|
|
Solution for Injection (IV)
|
Parenteral Nutrition
|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
|
China
|
-
|
05 May 2022
|
14 June 2026
|
| View |
|
DRP-10782-02
|
Epinephrine
|
Epimeds
|
1mg/mL
|
Solution for Injection (I.M./S.C./I.V.)
|
Adrenergic Agent and Beta-adrenoreceptor Agonist)
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
-
|
06 May 2022
|
18 November 2026
|
| View |
|
DRP-9975-04
|
Cefuroxime (as axetil)
|
Zurevee
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
-
|
06 May 2022
|
01 July 2026
|
| View |
|
DRP-8873-02
|
Paracetamol
|
SONGESIC IV
|
10mg/mL (1g/100mL)
|
Solution for I.V. Infusion
|
Analgesic /Antipyretic
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
-
|
06 May 2022
|
21 May 2025
|
| View |
|
DRP-6141-01
|
Tigecycline
|
Tigec
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
Antibacterial
|
Lyka Labs Ltd
|
India
|
Renewal
|
25 July 2024
|
06 May 2030
|
| View |
|
DRP-4838-06
|
Fenofibrate
|
Fenok
|
200 mg
|
Capsule
|
Lipid Modifying Agent (Fibrates)
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
Renewal
|
12 November 2023
|
16 October 2028
|
| View |
|
DRP-4787-01
|
Fluconazole
|
Flucofarm
|
2 mg/mL
|
Solution for IV Infusion
|
Antifungal
|
Amanta Healthcare Ltd.
|
India
|
Renewal
|
07 March 2023
|
04 October 2028
|
| View |
|
DRP-9078-01
|
Sitagliptin (as phosphate)
|
Gliptadin-50
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
-
|
09 May 2022
|
31 October 2025
|
| View |
DRP-8586-12_PI_01.pdf
|
DRP-8586-12
|
Trimetazidine dihydrochloride
|
Angifuse
|
35 mg
|
Modified-Release Tablet
|
Anti-Angina
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
21 March 2024
|
18 December 2029
|
| View |
|
DRP-4791-04
|
Gabapentin
|
Nuropin-100
|
100 mg
|
Capsule
|
Anticonvulsant
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
03 November 2022
|
04 October 2028
|
| View |
|
DRP-3158-03
|
Levofloxacin (as hemihydrate)
|
Unbranded
|
500 mg
|
Film-Coated Tablet
|
Antibacterials (Flouroquinolones)
|
Stallion Laboratories Pvt. Ltd
|
India
|
Renewal
|
28 March 2024
|
11 August 2029
|
| View |
|
HRP-445
|
2,4-Dichlorobenzyl Alcohol + Amylmetacresol
|
Therasil (Orange flavor)
|
1.2 mg/600 mcg
|
Lozenge
|
-
|
Plethico Pharmaceuticals Limited
|
India
|
Automatic Renewal
|
06 March 2022
|
24 April 2027
|